Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+ Cells Modified with a βAS3-Globin Lentiviral Vector

Fabrizia Urbinati, Ph.D, Zulema Romero Garcia, Ph.D, Sabine Geiger, Rafael Ruiz de Assin, Ph.D, Gabriela Kuftinec, Roger P. Hollis, PhD, Satiro N. De Oliveira, MD, Jennifer Wherley, Aaron Cooper, Tim M. Townes, PhD, Gay M. Crooks, MBBS, Elizabeth J Read, MD, Mark C. Walters, MD, Herbert J. Meiselman, ScD, Thomas D. Coates, MD, Victor J. Marder, M.D., Donald B. Kohn, MD

Blood (2011) 118 (21): 3119.

https://doi.org/10.1182/blood.V118.21.3119.3119

Published: 2011

Journal Articles

Successful Translation of a GMP-Based, Clinical Scale Selective Allodepletion Approach for Matched Donor-Recipient Pairs from Bench-to-Bedside.

Stephan Mielke, MD, Raquel Nunes, MD, Katayoun Rezvani, MD, PhD, Vicki S. Fellowes, Annie Venne, Scott R. Solomon, MD, Yong Fan, MD, Christian Scotto, PhD, Elizabeth J. Read, MD, A. John Barrett, MD

Blood (2007) 110 (11): 3279.

https://doi.org/10.1182/blood.V110.11.3279.3279

Published: 2007

Journal Articles

Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts Preserves a CD25− CD4+foxp3+ Fraction of T Cells and Thereby Provides a Source for Efficient Reconstitution of Regulatory T Cells and Additional GVHD Control.

Stephan Mielke, MD, Katayoun Rezvani, MD, PhD, Scott R. Solomon, MD, Bipin N. Savani, MD, Raquel Nunes, MD, Agnes Yong, MD, PhD, John Schindler, PhD, Elizabeth J. Read, MD, Ellen S. Vitetta, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 308.

https://doi.org/10.1182/blood.V108.11.308.308

Published: 2006

Journal Articles

Total Lymphocyte and Natural Killer (NK) Cell Count Day 30 Post-Transplant Strongly Predict Transplant Outcome after T Cell Depleted Allogeneic Stem Cell Transplantation.

Bipin N. Savani, MD, Stephan Mielke, MD, Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Nancy Hensel, Elizabeth J. Read, MD, Richard Childs, A. John Barrett, MD

Blood (2006) 108 (11): 2993.

https://doi.org/10.1182/blood.V108.11.2993.2993

Published: 2006

Journal Articles

High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs.

Stephan Mielke, MD, Raquel Nunes, MD, Katayoun Rezvani, MD, PhD, Vicki S. Fellowes, Yong Fan, MD, Scott R. Solomon, MD, Christian Scotto, PhD, Elizabeth J. Read, MD, A. John Barrett, MD

Blood (2006) 108 (11): 721.

https://doi.org/10.1182/blood.V108.11.721.721

Published: 2006

Journal Articles

Reconstitution of Regulatory T Cells after Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts and Association with Acute Graft-Versus-Host-Disease.

Stephan Mielke, MD, Katayoun Rezvani, MD, PhD, Scott R. Solomon, MD, Yasemin Kilical, Bipin N. Savani, MD, Laura Wish, Charles S. Carter, John Schindler, PhD, Nancy Hensel, Roger Kurlander, MD, Elizabeth J. Read, MD, Ellen S. Vitetta, PhD, A. John Barrett, MD

Blood (2005) 106 (11): 595.

https://doi.org/10.1182/blood.V106.11.595.595

Published: 2005

Journal Articles

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Vicki Fellowes, Jacopo Mariotti, MD, Charles Carter, Carl June4, MD, Bruce L. Levine4, PhD, Frances Hakim, PhD, Robert Vonderheide4, MD, DPhil, Ronald Gress, MD, Elizabeth J. Read, MD, Daniel Fowler, MD, Michael R. Bishop, MD

Blood (2005) 106 (11): 5407.

https://doi.org/10.1182/blood.V106.11.5407.5407

Published: 2005

Journal Articles

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Sakti Chakrabarti, MD, Igor Espinoza-Delgado, MD, Teresa Donohue, Susan Leitman, MD, Charles D. Bolan, MD, Elizabeth J. Read, MD, John A. Barrett, MD, Richard W. Childs, MD

Blood (2004) 104 (11): 1236.

https://doi.org/10.1182/blood.V104.11.1236.1236

Published: 2004

NARROW

Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+ Cells Modified with a βAS3-Globin Lentiviral Vector

Successful Translation of a GMP-Based, Clinical Scale Selective Allodepletion Approach for Matched Donor-Recipient Pairs from Bench-to-Bedside.

Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts Preserves a CD25− CD4+foxp3+ Fraction of T Cells and Thereby Provides a Source for Efficient Reconstitution of Regulatory T Cells and Additional GVHD Control.

Total Lymphocyte and Natural Killer (NK) Cell Count Day 30 Post-Transplant Strongly Predict Transplant Outcome after T Cell Depleted Allogeneic Stem Cell Transplantation.

High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs.

Reconstitution of Regulatory T Cells after Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts and Association with Acute Graft-Versus-Host-Disease.

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only